Grantham, Mayo, Van Otterloo & Co (GMO)
PDLI

Grantham, Mayo, Van Otterloo & Co (GMO)’s PDL BioPharma, Inc. PDLI Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-980,800
Closed -$3.09M – 921
2020
Q3 		$3.09M Sell
980,800
-127,100
-11% -$406K 0.02% 326
2020
Q2 		$3.22M Buy
1,107,900
+113,600
+11% +$359K 0.02% 324
2020
Q1 		$2.8M Sell
994,300
-137,700
-12% -$444K 0.02% 339
2019
Q4 		$3.67M Sell
1,132,000
-197,600
-15% -$574K 0.02% 327
2019
Q3 		$2.87M Sell
1,329,600
-349,300
-21% -$934K 0.02% 369
2019
Q2 		$5.27M Sell
1,678,900
-4,900
-0.3% -$15.9K 0.04% 282
2019
Q1 		$6.26M Buy
+1,683,800
New +$5.68M 0.05% 232
2017
Q2 		– Sell
-63,997
Closed -$145K – 673
2017
Q1 		$145K Sell
63,997
-1,006,512
-94% -$2.23M ﹤0.01% 556
2016
Q4 		$2.27M Sell
1,070,509
-1,224,725
-53% -$3.42M 0.01% 305
2016
Q3 		$7.69M Sell
2,295,234
-557,868
-20% -$1.77M 0.04% 225
2016
Q2 		$8.96M Buy
2,853,102
+395,987
+16% +$1.32M 0.04% 239
2016
Q1 		$8.18M Buy
2,457,115
+2,260,415
+1,149% +$7.05M 0.03% 253
2015
Q4 		$696K Sell
196,700
-2,300
-1% -$9.63K ﹤0.01% 418
2015
Q3 		$1M Buy
+199,000
New +$1.14M ﹤0.01% 403
2014
Q1 		– Sell
-42,543
Closed -$359K – 725
2013
Q4 		$359K Sell
42,543
-5,064
-11% -$42.7K ﹤0.01% 603
2013
Q3 		$379K Sell
47,607
-9,326
-16% -$75K ﹤0.01% 594
2013
Q2 		$440K Buy
+56,933
New +$444K ﹤0.01% 551

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PDLI Position: Q4 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 980,800 shares — an estimated $3.09M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PDLI in Q2 2013 and held it in 17 quarters. The position peaked at $8.96M in Q2 2016. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 980,800 PDL BioPharma, Inc. shares in Q4 2020, an estimated $3.09M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 17 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s PDL BioPharma, Inc. position peaked at $8.96M in Q2 2016.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2020, filed 12 Feb 2021.